RecruitingPhase 1Phase 2NCT02272049

Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults

Use of Hyperpolarized 129 Xe MR Lung Imaging in Children and Adults


Sponsor

Children's Hospital Medical Center, Cincinnati

Enrollment

300 participants

Start Date

Dec 1, 2014

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to evaluate the usefulness of hyperpolarized (HP) 129Xe (xenon) gas MRI for regional assessment of lung function in a normal population of children and adults and in adults and also in children with respiratory compromise due to a variety of diseases.


Eligibility

Min Age: 6 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Hyperpolarized 129 Xenon for people with respiratory disorders. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGHyperpolarized 129 Xenon

During the scans, subject will inhale hyperpolarized Xenon gas for up to 16 seconds per scan, for up to 4 separate MR scans


Locations(1)

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02272049


Related Trials